TelyRx Holdings Inc.
TELY.TO
TSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 205.53% | 327.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 205.53% | 327.77% | |||
| Cost of Revenue | 91.35% | 211.65% | |||
| Gross Profit | 299.49% | 618.08% | |||
| SG&A Expenses | 307.95% | 716.73% | |||
| Depreciation & Amortization | 156.13% | 188.89% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 213.79% | 352.18% | |||
| Operating Income | -264.11% | -1,655.56% | |||
| Income Before Tax | -159.52% | 83.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -159.87% | 83.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -247.03% | 84.80% | |||
| EBIT | -264.11% | -1,655.56% | |||
| EBITDA | -261.11% | -6,860.15% | |||
| EPS Basic | -222.47% | 86.20% | |||
| Normalized Basic EPS | -220.64% | -207.96% | |||
| EPS Diluted | 58.23% | 86.07% | |||
| Normalized Diluted EPS | -220.64% | -207.96% | |||
| Average Basic Shares Outstanding | 7.54% | 10.15% | |||
| Average Diluted Shares Outstanding | 7.54% | 10.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||